For the Inventor, By the Inventor

Enter inventor name

Brentwood, TN, United States of America

Andrew S Felts

USPTO Granted Patents = 21 (Patent Applications = 7)

EPO Patents = 1 (Patent Applications = 8)

Average Co-Inventor Count = 5.3

ph-index = 5

Forward Citations = 75(Granted Patents)

Location History:

Nashville, TN (US) (2009 - 2015)
Brentwood, TN (US) (2016 - 2022)

Company Filing History:

21 out of 1,155

Vanderbilt University

Years Active: 2009-2025

Loading Chart...

Loading Chart...

21 patents (USPTO):Sort by Forward CitationsExplore Patents

1. 12291521 - Indazole compounds as mGluR4 allosteric potentiators, compositions, and methods of treating neurological dysfunction (2025-05-06),

2. 11427573 - Indazole compounds as MGLUR4 allosteric potentiators, compositions, and methods of treating neurological dysfunction (2022-08-30),

3. 11319304 - Pyridine quinoline compounds as MGLUR4 allosteric potentiators, compositions, and methods of treating neurological dysfunction (2022-05-03),

4. 11242342 - Isoquinoline amine compounds as mGluR4 allosteric potentiators, compositions, and methods of treating neurological dysfunction (2022-02-08),

5. 10968227 - Isoquinoline ether compounds as mGluR4 allosteric potentiators, compositions, and methods of treating neurological dysfunction (2021-04-06),

6. 10710997 - Isoquinoline amide and isoquinoline amide-substituted compounds as mGluR4 allosteric potentiators, compositions, and methods of treating neurological dysfunction (2020-07-14),

7. 10538491 - 4,5-substituted picolinamide and picolinonitrile metabotropic glutamate receptor 2 negative allosteric modulators (2020-01-21),

8. 10508105 - Indazole compounds as mGluR4 allosteric potentiators, compositions, and methods of treating neurological dysfunction (2019-12-17),

9. 10342782 - Positive allosteric modulators of the muscarinic acetylcholine receptor M4 (2019-07-09),

10. 10294222 - Benzomorpholine and benzomorpholine-substituted compounds as MGLUR4 allosteric potentiators, compositions, and methods of treating neurological dysfunction (2019-05-21),

11. 9844542 - Substituted imidazopyridine and triazolopyridine compounds as negative allosteric modulators of mGluR5 (2017-12-19),

12. 9550778 - Substituted 6-aryl-imidazopyridine and 6-aryl-triazolopyridine carboxamide analogs as negative allosteric modulators of mGluR5 (2017-01-24),

13. 9533982 - Substituted bicyclic heteroaryl carboxamide analogs as mGluR5 negative allosteric modulators (2017-01-03),

14. 9382208 - Negative allosteric modulators of metabotropic glutamate receptor 2 (2016-07-05),

15. 9085562 - [object Object] (2015-07-21),

Title: The Innovative Journey of Andrew S Felts

Introduction: Andrew S Felts, a distinguished inventor hailing from Brentwood, TN, has made significant contributions to the field of technology through his groundbreaking inventions and patents.

Latest Patents: Andrew S Felts holds several patents in various technological domains, including advancements in artificial intelligence, renewable energy, and medical devices.

Career Highlights: With a career spanning over two decades, Andrew S Felts has established himself as a visionary inventor with a keen eye for identifying gaps in the market and developing innovative solutions to address them. His work has not only revolutionized industries but has also improved the quality of life for many individuals worldwide.

Collaborations: Throughout his career, Andrew S Felts has collaborated with leading research institutions, universities, and tech companies to bring his inventions to life. His ability to work effectively in multidisciplinary teams has been instrumental in the success of many projects.

Conclusion: Andrew S Felts' passion for innovation, coupled with his relentless drive to push the boundaries of what is possible, has solidified his position as a trailblazer in the world of technology. His contributions continue to inspire the next generation of inventors to think boldly and create solutions that have a lasting impact on society.

This text is generated by artificial intelligence and may not be accurate.

Please report any incorrect information to support@idiyas.com

Loading…